|
(Health-NewsWire.Net, August 30, 2021 ) Cardiac assist devices (CAD), also known as Ventricular Assist Devices (VAD), Total Artificial Cardiac (TAH), and Intra-Aortic Balloon Pump (IABP), are used to treat a variety of heart problems, including end-stage heart failure, refractory angina pectoris, post-cardiopulmonary bypass shock, myocardial infarction, myocarditis, and others. VSD is a mechanical pump that assists the heart in pumping oxygenated blood to the rest of the body by lowering the burden of the left or right ventricles.
The cardiac assist devices market is driven by the increasing prevalence of cardiovascular diseases, the availability of novel treatments, the affordability of medical devices, the widespread use and acceptance of cardiac assist devices in developing markets, and medical device innovation and development. Furthermore, the world's ageing population and a scarcity of organ donors are increasing the use of cardiac assist devices in patients with severe heart problems. However, stiff rivalry among existing companies, complications and harshness of treatment, and a lack of knowledge among the rural population in developing and underdeveloped economies are anticipated to constrain the cardiac assist devices market.
Request a Sample of this research @ https://whipsmartmi.com/sample/he0802/Cardiac-Assist-Devices-Market
The Cardiac Assist Devices market study includes regional information for North America, Europe, Asia Pacific, and the Rest of the World. The Cardiac Assist Devices market is divided into main nations such as the United States, Canada, Germany, the United Kingdom, France, Italy, China, India, Japan, Brazil, South Africa, and others.
This report offers the major market player’s profiles, such as Abiomed, Berlin Heart, CardiacAssist, Inc., Cardiobridge GmbH, Carmat, HeartWare, Jarvik Heart, Inc., XENIOS AG, MiTiHeart Corporation, and SynCardia Systems, LLC.
The Cardiac Assist Devices Market report has been categorized as below
By Product
Ventricular assist devices
Intra-aortic balloon pumps (IABPs)
Total artificial heart
By Modality
Transcutaneous
Implantable
By Application
Bridge-to-transplant (BTT) therapy
Destination therapy
Bridge-to-recovery (BTR) therapy
Bridge-to-candidacy (BTC) therapy
By Region
North America
Europe
Asia Pacific
Rest of World
About whipsmartmi:
We are a growth partnership company that provides fact-based consulting services focused on helping our clients achieve incremental and transformational growth competing in business-to- business and business-to- consumer markets. We facilitate their growth journey through an environment that is dominated by accelerating change, constant evolution of new business models, disruptive trends and technologies in their respective industry.
We serve a wide spectrum of global industries such as Semiconductor and Electronics, Information Technology, Communication, Medical Devices, Pharmaceuticals, Defense, Aviation, and Chemicals among others. Our well-seasoned blend of technical and marketing expertise enables us to serve our customers with comprehensive study of global supply chains that helps them to devise highly effective strategies.
Whipsmart Market Intelligence blog
Whipsmart Market Intelligence Press Releases
Whipsmart
Neeraj
5102005090
neeraj@whipsmartmi.com
Source: EmailWire.Com 
|
